ValiRx plc (VAL) — Strategic Asset Allocation Index
ValiRx plc (VAL) has a Strategic Asset Allocation Index of 7.0% as of June 2023. Strategic assets (PP&E of £276.45K plus long-term investments of £-) total £276.45K, measured against net assets of £3.95 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are ValiRx plc's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
ValiRx plc Strategic Asset Allocation Index (2013–2022)
This chart shows how ValiRx plc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2013 to 2022. As of June 2023, the index stands at 7.0%, representing strategic assets of £276.45K against net assets of £3.95 Million GBP. See ValiRx plc (VAL) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for ValiRx plc (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ValiRx plc from 2013 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see VAL market cap.
| Year | SAAI | Strategic Assets (GBP) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | £5.56K | £5.56K | £- | £3.83 Million | ▼ -0.2 pp |
| 2021 | 0.4% | £13.28K | £13.28K | £- | £3.41 Million | ▼ -0.1 pp |
| 2020 | 0.4% | £21.00K | £21.00K | £- | £4.76 Million | ▼ 0.0 pp |
| 2016 | 0.4% | £10.55K | £10.55K | £- | £2.37 Million | ▼ 0.0 pp |
| 2015 | 0.5% | £22.18K | £22.18K | £- | £4.53 Million | ▲ +0.4 pp |
| 2014 | 0.1% | £1.51K | £1.51K | £- | £2.79 Million | ▼ -23.8 pp |
| 2013 | 23.8% | £769.01K | £685.00 | £768.32K | £3.23 Million | — |